Backgrounds

1. [|FDA Critical path initiative: Warfarin dosing]

2. [|FDA safety alerts for human medical products: Warfarin]

3. [|Singapore Ministry of Health: Warfarin dosing guidline]

4. [|UPenn multicenter genotyped warfarin dosing clinical trial]